Nohla Therapeutics Inc.
Formerly Cytomatrix Therapeutics, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Nohla Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).
SEC Form D · May 2018
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2018
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Nohla Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Colleen Delaney | Executive officer | May 2018 |
| Gary Christianson | Executive officer | May 2018 |
| Jim Johnson | Executive officer | May 2018 |
| Kathleen Fanning | Executive officer | May 2018 |
| Darren Scotti | Executive officer | Dec 2016 |
| Michael Sistenich | Executive officer | Dec 2016 |
| Benjamin Scot Bergo | Executive officer | Dec 2015 |
| Darren David Scotti | Executive officer | Dec 2015 |
| Brian Daniels | Director | May 2018 |
| Kathleen Fanning | Director | May 2018 |
| Lawrence Gozlan | Director | May 2018 |
| Michael Sistenich | Director | May 2018 |
| Steven Gillis | Director | May 2018 |
| Benjamin Scot Bergo | Director | Dec 2015 |
| Ian David Brown | Director | Dec 2015 |
| Lawrence David Gozlan | Director | Dec 2015 |
| Benjamin Scot Bergo | Promoter | Dec 2015 |